1. Home
  2. BMA vs PTCT Comparison

BMA vs PTCT Comparison

Compare BMA & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco Macro S.A.  ADR (representing Ten Class B)

BMA

Banco Macro S.A. ADR (representing Ten Class B)

HOLD

Current Price

$71.61

Market Cap

4.9B

Sector

Finance

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$66.72

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMA
PTCT
Founded
1966
1998
Country
Argentina
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.5B
IPO Year
2006
2006

Fundamental Metrics

Financial Performance
Metric
BMA
PTCT
Price
$71.61
$66.72
Analyst Decision
Strong Buy
Buy
Analyst Count
5
16
Target Price
$96.75
$80.94
AVG Volume (30 Days)
404.8K
970.9K
Earning Date
02-26-2026
05-05-2026
Dividend Yield
4.63%
N/A
EPS Growth
N/A
264.48
EPS
N/A
7.78
Revenue
N/A
$264,734,000.00
Revenue This Year
$15.45
N/A
Revenue Next Year
$11.59
$19.30
P/E Ratio
$33.22
$8.27
Revenue Growth
N/A
36.19
52 Week Low
$38.30
$35.95
52 Week High
$106.15
$87.50

Technical Indicators

Market Signals
Indicator
BMA
PTCT
Relative Strength Index (RSI) 42.29 46.70
Support Level $67.15 $61.43
Resistance Level $94.68 $69.29
Average True Range (ATR) 3.83 2.46
MACD 0.76 0.28
Stochastic Oscillator 54.80 49.11

Price Performance

Historical Comparison
BMA
PTCT

About BMA Banco Macro S.A. ADR (representing Ten Class B)

Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: